RadNet (RDNT) To Report Earnings Tomorrow: Here Is What To Expect
RadNet (NASDAQ: RDNT) will report earnings tomorrow after market close. The company previously beat revenue expectations with $575.6 million in revenue, up 22.1% year over year, but missed EPS estimates. For the upcoming quarter, analysts expect revenue growth of 22.1% YoY. The article cites an average analyst price target of $89.75 versus a $71.57 share price.
How this was made
The 30-second read
Why it matters
Traders can use the cited consensus revenue growth and the prior EPS miss as a baseline for positioning into the after-close earnings print, but there is no new disclosure such as updated guidance or a fresh filing.
Market read
This is primarily an earnings-timing and expectation setup for RDNT, with some peer read-through and recent price momentum context.
What to watch
No details are provided on margins, cash flow, guidance changes, or management commentary, which are typically the key drivers of post-earnings repricing.
Background
The piece is a pre-earnings preview for RadNet, referencing last quarter’s revenue beat and EPS miss, plus consensus expectations for the upcoming quarter.
Ticker impact
RadNet (RDNT) is scheduled to report earnings next after the close, with the article citing consensus revenue growth and prior quarter results.
Likely volatility around the after-close print, with direction dependent on EPS versus the cited analyst miss and any commentary on revenue growth.
The text provides timing (next after market close) and expectation framing (revenue growth 22.1% YoY, prior quarter EPS miss) but no fresh company disclosure like guidance, revisions, or a new event.
Market effects
Testing and diagnostics services sentiment is described as positive, which can support relative positioning into earnings.
No specific regional impact is disclosed.
No global macro or cross-border catalyst is disclosed.
Counterpoint
The article highlights a prior EPS miss, so upside may be limited if the company’s earnings power remains pressured despite revenue growth.
Key entities
- companyRadNet
Diagnostic imaging company scheduled to report earnings next after market close; article cites prior quarter revenue beat and EPS miss plus consensus revenue growth.
- companyQuest Diagnostics
Peer mentioned as having reported Q2 results with revenue growth and a stock reaction.
- companyGuardant Health
Peer mentioned as having reported Q2 revenues up sharply and a stock reaction.
